Assessment of CR6261, a Monoclonal Antibody Against the Influenza A Virus
Clinical trial NCT01406418 · COMPLETED
Trial details
- NCT number
- NCT01406418
- Sponsor
- Crucell Holland BV
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-02-01
- Primary completion
- 2013-11-01
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.